Skip to main content
Year archive

SAM CHUN DANG PHARM CO. LTD — 2019 filings

All 18 regulatory filings released by SAM CHUN DANG PHARM CO. LTD (000250) in 2019, sourced directly from the official regulator.

18 Filings
2019 Period
2019 filings (18)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2019-12-16 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
전환가액의조정
Capital/Financing Update
2019-08-19 Korean
신주인수권행사가액의조정
Share Issue/Capital Change
2019-08-19 Korean
[기재정정]반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-16 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-14 Korean
단일판매ㆍ공급계약체결(자율공시)
Capital/Financing Update
2019-05-21 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
사업보고서 (2018.12)
Audit Report / Information FY 2018
2019-03-29 Korean
투자판단관련주요경영사항(황반변성치료제(주성분: Aflibercept) 바이오시밀러 SCD411의 일본 독점판매권 및 공급계약 체결)
M&A Activity
2019-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-15 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-02-22 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2019-02-19 Korean
기업설명회(IR)개최
Investor Presentation
2019-02-07 Korean
수시공시의무관련사항(공정공시)(Binding Financial Term Sheet 체결)
Regulatory Filings
2019-01-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2019-01-18 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2019-01-18 Korean